Trilafon



Indications and Reactions:

Role Indications Reactions
Primary
Psychotic Disorder 14.1%
Depression 10.9%
Schizophrenia 9.4%
Schizophrenia, Paranoid Type 9.4%
Product Used For Unknown Indication 7.8%
Schizoaffective Disorder Depressive Type 7.8%
Anxiety 6.3%
Injury 6.3%
Obstruction 6.3%
Schizoaffective Disorder 4.7%
Metabolic Disorder 3.1%
Pain 3.1%
Drug Therapy 1.6%
Epilepsy 1.6%
Ex-tobacco User 1.6%
Hypertension 1.6%
Neurosis 1.6%
Panic Attack 1.6%
Post Concussion Syndrome 1.6%
Speech Disorder Developmental 8.3%
Supraventricular Tachycardia 8.3%
Tardive Dyskinesia 8.3%
Weight Increased 8.3%
Asthenia 4.2%
Cognitive Disorder 4.2%
Confusional State 4.2%
Drug Ineffective 4.2%
Epilepsy 4.2%
Foetal Exposure During Pregnancy 4.2%
Insomnia 4.2%
Muscular Weakness 4.2%
Nervous System Disorder 4.2%
Neuroleptic Malignant Syndrome 4.2%
Neurological Examination Abnormal 4.2%
Oesophageal Atresia 4.2%
Rotator Cuff Syndrome 4.2%
Suicidal Ideation 4.2%
Suicide Attempt 4.2%
Transient Ischaemic Attack 4.2%
Secondary
Schizophrenia 18.1%
Schizophrenia, Paranoid Type 17.5%
Product Used For Unknown Indication 11.8%
Depression 10.6%
Anxiety 7.6%
Psychotic Disorder 7.3%
Drug Use For Unknown Indication 6.0%
Epilepsy 3.3%
Injury 2.4%
Obstruction 2.4%
Foetal Exposure During Pregnancy 2.1%
Bipolar Disorder 1.8%
Hallucination 1.8%
Mental Disorder 1.5%
Pain 1.2%
Adverse Event 0.9%
Asperger's Disorder 0.9%
Blood Cholesterol 0.9%
Dementia 0.9%
Laxative Supportive Care 0.9%
Weight Increased 30.0%
Blood Cholesterol Increased 6.0%
Extrapyramidal Disorder 6.0%
Latent Autoimmune Diabetes In Adults 6.0%
Tension 6.0%
Vitamin K Deficiency 6.0%
Maternal Drugs Affecting Foetus 4.0%
Neuroleptic Malignant Syndrome 4.0%
Psychotic Disorder 4.0%
Retinopathy 4.0%
Vitreous Disorder 4.0%
Withdrawal Syndrome 4.0%
Alopecia 2.0%
Asthenia 2.0%
Chronic Obstructive Pulmonary Disease 2.0%
Drug Abuse 2.0%
Drug Hypersensitivity 2.0%
Drug Ineffective 2.0%
Drug Withdrawal Syndrome Neonatal 2.0%
Foetal Exposure During Pregnancy 2.0%
Concomitant
Depression 18.4%
Schizophrenia 17.4%
Bipolar Disorder 16.4%
Anxiety 7.7%
Sleep Disorder 5.7%
Major Depression 4.0%
Psychotic Disorder 4.0%
Schizoaffective Disorder 3.4%
Insomnia 3.1%
Pain 3.0%
Hypertension 2.2%
Mental Disorder 2.0%
Schizophrenia, Paranoid Type 1.9%
Agitation 1.9%
Product Used For Unknown Indication 1.7%
Diabetes Mellitus 1.5%
Drug Use For Unknown Indication 1.4%
Hallucination, Auditory 1.4%
Hyperlipidaemia 1.4%
Affective Disorder 1.3%
Type 2 Diabetes Mellitus 33.7%
Weight Increased 13.0%
Pancreatitis 9.7%
Tardive Dyskinesia 9.4%
Diabetes Mellitus 5.8%
Tearfulness 3.3%
Type 1 Diabetes Mellitus 3.3%
Death 2.2%
Vomiting 2.2%
Wheelchair User 2.2%
Diabetic Ketoacidosis 1.7%
Obesity 1.7%
Sedation 1.7%
Urinary Tract Infection 1.7%
Uterine Leiomyoma 1.7%
Vision Blurred 1.7%
Diabetic Coma 1.4%
Suicide Attempt 1.4%
Vulvovaginal Candidiasis 1.4%
Diabetic Neuropathy 1.1%
Interacting
Hallucination 25.0%
Dementia 12.5%
Depression 12.5%
Hepatitis C 12.5%
Hiv Infection 12.5%
Schizoaffective Disorder 12.5%
Extrapyramidal Disorder 6.3%
Schizophrenia 6.3%
Extrapyramidal Disorder 40.0%
Priapism 20.0%
Pyrexia 20.0%
Toxicity To Various Agents 20.0%